top of page

Montelukast (Singulair): Uses, the FDA Boxed Warning, Side Effects and Safer Alternatives (2026 Guide)

Nov 6
5 min read

Montelukast, sold as Singulair and as generics, is a once-daily tablet used for asthma and allergies. It has been on the market since 1998 and is prescribed to both adults and children. Many people take it without knowing that, since 2020, it has carried the FDA's most prominent safety warning, a boxed warning about serious mental health side effects.


This guide explains what montelukast does, what the warning says, which symptoms to watch for, and which alternatives are usually tried first. If you or your child takes montelukast, do not stop it without talking to a clinician, unless you notice the mood or behavior changes described below, in which case contact a doctor promptly.


For rescue treatment of asthma attacks, see our guide: [Albuterol (Ventolin/ProAir): Complete 2026 Guide]


Montelukast (Singulair): Uses, the FDA Boxed Warning, Side Effects and Safer Alternatives (2026 Guide)

What Montelukast Is Used For


Use

What it means

FDA guidance

Asthma (long-term control)

Taken daily to reduce asthma symptoms and flare-ups

Use should follow careful consideration of risks and benefits

Exercise-induced bronchoconstriction

Taken before exercise to prevent airway narrowing

Same caution applies

Allergic rhinitis (hay fever and year-round allergies)

Reduces sneezing, runny nose and congestion

Reserve for people whose symptoms have not responded to, or who cannot tolerate, other treatments


Montelukast is not a rescue medicine. It does not stop an asthma attack that has already started. A quick-relief inhaler is used for that.


How It Works


Leukotrienes are chemicals released during allergic reactions and asthma. They tighten the airways, increase mucus and cause swelling. Montelukast blocks the receptor that leukotrienes act on (the cysteinyl leukotriene receptor), which reduces these effects. It is not a steroid. For most people with persistent asthma, an inhaled corticosteroid is the usual first-line controller, and montelukast is an alternative or an add-on chosen by the prescriber.


The FDA Boxed Warning


In March 2020, the FDA required a boxed warning, its most prominent warning, for montelukast because of serious neuropsychiatric events. The agency also required a Medication Guide to be given with each prescription. Key points from the FDA and medical literature:


  • The warning strengthened an existing label warning about agitation, depression and suicidal thoughts and actions.

  • The FDA said the incidence of these events is unknown, but some reports are serious, and many patients and professionals were not fully aware of the risk.

  • The FDA's review of reports identified cases of completed suicide, many preceded by new mental health symptoms. The reports have limits, and the circumstances varied.

  • Several large observational studies have found no association between montelukast and neuropsychiatric events, while one case-control study in children found such events almost twice as often in those taking montelukast than in those taking other asthma drugs. The evidence is therefore mixed, which is partly why the FDA chose to warn rather than withdraw the drug.

  • For allergic rhinitis, the FDA advised that montelukast be used only when other treatments have been ineffective or are not tolerated, because safer options exist.

  • A May 2026 provider notice from a health plan repeated the FDA guidance: avoid prescribing for mild symptoms, discuss risks with patients and caregivers, monitor for mood or behavior changes, and stop montelukast immediately if neuropsychiatric symptoms occur.


Warning Signs and What to Do


Reported signs

What to do

Agitation, aggression or hostility

Stop the medicine and call the prescriber

Depression, anxiety, irritability, restlessness

Stop the medicine and call the prescriber

Trouble sleeping, bad or vivid dreams, sleepwalking

Stop the medicine and call the prescriber

Memory or attention problems, confusion, tremor

Stop the medicine and call the prescriber

Hallucinations or unusual thoughts

Stop the medicine and seek urgent medical care

Thoughts of suicide or self-harm

Seek emergency help immediately, call or text 988 in the US, and tell the prescriber


Symptoms can begin soon after starting or after months of use, and in children they may show as behavior or sleep changes. Parents should ask about mood and sleep, not only breathing.


Dosing Basics


Always follow the prescriber and the label. Typical points:

  • Adults and teenagers usually take one 10 mg tablet once daily. For asthma it is taken in the evening.

  • Children take lower, age-based doses, usually chewable tablets or granules.

  • For exercise-induced symptoms, it is taken before exercise as directed on the label and not repeated within 24 hours.

  • Chewable tablets contain phenylalanine, which matters for people with phenylketonuria.

  • Montelukast should not replace a rescue inhaler or an inhaled steroid unless the prescriber says so.


Tell your prescriber about all your medicines, because some drugs can change montelukast levels.


Other Side Effects


Common effects include headache, stomach pain, upper respiratory infection, tiredness, cough and rash. Rarely, an inflammatory condition affecting blood vessels has been reported, mostly when oral steroid doses were being reduced. Seek care for new rash, numbness, severe sinus symptoms or worsening breathlessness.


Alternatives Usually Tried First


For

Options often tried first

Allergic rhinitis

Intranasal corticosteroid sprays (such as fluticasone, triamcinolone or budesonide); second-generation oral antihistamines; allergen immunotherapy (allergy shots or tablets); avoiding triggers

Persistent asthma

Inhaled corticosteroid, with or without a long-acting bronchodilator, as set out in the asthma guidelines

Exercise-induced symptoms

A pre-exercise reliever inhaler as directed, plus better overall asthma control


Your clinician can tell you whether one of these is better suited to you or your child.


When to Seek Urgent Care


Call emergency services for thoughts of suicide or self-harm, severe shortness of breath, lips turning blue, or an asthma attack that does not improve with a rescue inhaler. See a doctor soon for any mood, behavior or sleep changes after starting montelukast.


The FDA Drug Safety Communication is available at: https://www.fda.gov/media/135840/download


The Medical Letter summary of the warning is available at: https://secure.medicalletter.org/w1597a


A May 2026 provider notice repeating the guidance is available at: https://countycare.com/wp-content/uploads/Provider-Notice-Montelukast_5.19.26.pdf



Frequently Asked Questions


What is the FDA boxed warning on montelukast?

In March 2020 the FDA required a boxed warning, its most prominent warning, about serious neuropsychiatric events with montelukast, including agitation, depression, sleep problems and suicidal thoughts and actions. The FDA also required a Medication Guide and advised avoiding the drug for mild symptoms, particularly allergic rhinitis.

Reported signs include agitation or aggression, depression, anxiety, irritability, restlessness, trouble sleeping, vivid dreams, sleepwalking, memory or attention problems, tremor and hallucinations. If these occur, stop the medicine and contact the prescriber. Seek emergency help for thoughts of suicide, calling or texting 988 in the US.

It is approved for children at age-based doses, but the boxed warning applies to all ages, and children's changes may show up as behavior or sleep problems. Parents should discuss risks with the prescriber, watch for changes, and ask whether other treatments should be tried first.

The FDA suggests intranasal corticosteroid sprays such as fluticasone, triamcinolone or budesonide, second-generation antihistamines and allergen immunotherapy. For asthma, an inhaled corticosteroid is usually the first-line controller. Your clinician can recommend the best option.

If you notice mood, behavior or sleep changes, the FDA advises stopping it and talking to your doctor. Otherwise, discuss any change with your prescriber first, especially if you use it for asthma, so that your asthma remains controlled.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Montelukast requires a prescription and review by a licensed healthcare provider. If you or someone you know is having thoughts of suicide, call or text the 988 Suicide and Crisis Lifeline in the US, or call emergency services.

Comments


bottom of page